239 related articles for article (PubMed ID: 8944072)
21. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
22. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
23. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors.
Cardiff RD; Gumerlock PH; Soong MM; Dandekar S; Barry PA; Young LJ; Meyers FJ
Oncogene; 1988 Aug; 3(2):205-13. PubMed ID: 2842717
[TBL] [Abstract][Full Text] [Related]
24. Motif-primed polymerase chain reaction-based allelotype of sarcomas induced by 3-methylcholanthrene in interspecific hybrid mice.
Dudley ME; Sundberg JP; Roopenian DC
Oncogene; 1995 Aug; 11(3):517-24. PubMed ID: 7630636
[TBL] [Abstract][Full Text] [Related]
25. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
[TBL] [Abstract][Full Text] [Related]
26. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
27. [Experimental study of combination medical endocrine therapy on DMBA-induced mammary tumor, with special reference to the effect of drug-dose on various factors].
Kosaka A; Yamashita A
Gan To Kagaku Ryoho; 1992 Jan; 19(1):75-81. PubMed ID: 1530907
[TBL] [Abstract][Full Text] [Related]
28. Serial transplantation of chemical carcinogen-induced mouse mammary ductal dysplasias.
Medina D
J Natl Cancer Inst; 1979 Feb; 62(2):397-405. PubMed ID: 105203
[TBL] [Abstract][Full Text] [Related]
29. Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention.
Telang NT; Kurihara H; Wong GY; Bradlow HL; Osborne MP
Anticancer Res; 1991; 11(3):1021-7. PubMed ID: 1909512
[TBL] [Abstract][Full Text] [Related]
30. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
Ishikawa H; Iino Y; Izuo M; Takikawa H
Gan No Rinsho; 1986 Feb; 32(2):151-5. PubMed ID: 2937941
[TBL] [Abstract][Full Text] [Related]
31. [Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice].
Elizalde PV; Balaña ME; Charreau EH
Medicina (B Aires); 1997; 57 Suppl 2():70-4. PubMed ID: 9580484
[TBL] [Abstract][Full Text] [Related]
32. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat.
Isaacs JT
Cancer Res; 1986 Aug; 46(8):3958-63. PubMed ID: 3089584
[TBL] [Abstract][Full Text] [Related]
33. A transgenic mouse model for mammary carcinogenesis.
Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM
Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874
[TBL] [Abstract][Full Text] [Related]
34. Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
Benakanakere I; Besch-Williford C; Carroll CE; Hyder SM
Cancer Prev Res (Phila); 2010 Sep; 3(9):1157-67. PubMed ID: 20699413
[TBL] [Abstract][Full Text] [Related]
35. DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations.
Abba MC; Zhong Y; Lee J; Kil H; Lu Y; Takata Y; Simper MS; Gaddis S; Shen J; Aldaz CM
Oncotarget; 2016 Sep; 7(39):64289-64299. PubMed ID: 27588403
[TBL] [Abstract][Full Text] [Related]
36. Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma.
Cheung TH; Chung TK; Poon CS; Hampton GM; Wang VW; Wong YF
Cancer; 1999 Oct; 86(7):1294-8. PubMed ID: 10506716
[TBL] [Abstract][Full Text] [Related]
37. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
[TBL] [Abstract][Full Text] [Related]
38. Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.
Coffey RJ; Meise KS; Matsui Y; Hogan BL; Dempsey PJ; Halter SA
Cancer Res; 1994 Apr; 54(7):1678-83. PubMed ID: 8137281
[TBL] [Abstract][Full Text] [Related]
39. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
[TBL] [Abstract][Full Text] [Related]
40. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival.
Choi SW; Lee KJ; Bae YA; Min KO; Kwon MS; Kim KM; Rhyu MG
Clin Cancer Res; 2002 Jul; 8(7):2311-22. PubMed ID: 12114436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
